Petra Acquisition Inc.
Completed 2022-01-10- CIK 1810560
- PAIC
- Now REVB
- IPO 2020-10-13
- $48.3M trust
- 387 filings
Successfully merged with Revelation Biosciences, Inc. • Now trading as REVB
- IPO Size
- $72.8M
- raised at the IPO
- Trust
- $48.3M
- as of 2021-12-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
387 filings over 26 quarters; violet bars carry a milestone
- 20 Q2: 1 filing
- 20 Q3: 5 filings
- 20 Q4: 25 filings
- 21 Q1: 9 filings
- 21 Q2: 5 filings
- 21 Q3: 15 filings
- 21 Q4: 24 filings
- 22 Q1: 35 filings
- 22 Q2: 14 filings
- 22 Q3: 12 filings
- 22 Q4: 16 filings
- 23 Q1: 23 filings
- 23 Q2: 15 filings
- 23 Q3: 9 filings
- 23 Q4: 12 filings
- 24 Q1: 17 filings
- 24 Q2: 7 filings
- 24 Q3: 21 filings
- 24 Q4: 14 filings
- 25 Q1: 16 filings
- 25 Q2: 18 filings
- 25 Q3: 14 filings
- 25 Q4: 14 filings
- 26 Q1: 24 filings
- 26 Q2: 11 filings
- 26 Q3: 11 filings
- S-1 filed 20 Q2
- IPO 20 Q4
- Definitive agreement 21 Q3
- Completed 22 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Petra Acquisition, Inc. is a blank-check company formed to identify and combine with an operating business. It intends to focus on healthcare or healthcare-related businesses, including life sciences, medical technology, digital health and technology-enabled services, and assist the acquired business’s growth.
Investment Focus
Healthcare
Geographic Focus
United States
Key Information
As the filings state it
- IPO Date
- 2020-10-13
- Total Redemptions
- $61.3M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2022-01-10
- Merger Target
- Revelation Biosciences, Inc.
- SPAC Ticker
- PAIC
- Merged Ticker
- REVB
Stock Performance
REVBTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2020-11-17 | $9.75 | |
| At Merger | 2022-01-11 | $8.51 | -13% |
| 6 Months Post-Merger | 2022-07-13 | $1.18 | -86% |
| 1 Year Post-Merger | 2023-01-11 | $0.24 | -97% |
| 2 Years Post-Merger | 2024-01-11 | $0.47 | -94% |
| Current Price | 2026-10-14 | $0.72 | -93% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by healthcare, technology and financial-services entrepreneurs and investors with experience in healthcare capital markets, life sciences, digital health, M&A, investment banking and private equity; team includes Andreas Typaldos, Sean Fitzpatrick, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and Kimon Angelides.